Holen Sie sich die Stockscreener-App
0.3105
2.20%
-0.007
Handel nachbörslich:
.31
-0.0005
-0.16%
Schlusskurs vom Vortag:
$0.3175
Offen:
$0.3157
24-Stunden-Volumen:
1.70M
Relative Volume:
0.85
Marktkapitalisierung:
$7.91M
Einnahmen:
$486.00K
Nettoeinkommen (Verlust:
$-28.43M
KGV:
-0.1101
EPS:
-2.8189
Netto-Cashflow:
$-26.75M
1W Leistung:
-5.77%
1M Leistung:
-14.98%
6M Leistung:
-86.56%
1J Leistung:
-83.57%
1-Tages-Spanne:
$0.3053
$0.3157
1-Wochen-Bereich:
$0.3053
$0.3276
52-Wochen-Spanne:
$0.3053
$4.30
Vyne Therapeutics Inc Stock (VYNE) Company Profile
Firmenname
Vyne Therapeutics Inc
Sektor
Branche
Telefon
800-775-7936
Adresse
685 ROUTE 202/206 N., SUITE 301, BRIDGEWATER
Vergleichen Sie VYNE mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
VYNE
Vyne Therapeutics Inc
|
0.3105 | 8.21M | 486.00K | -28.43M | -26.75M | -2.8189 |
|
VRTX
Vertex Pharmaceuticals Inc
|
396.93 | 102.81B | 11.39B | 3.64B | 3.50B | 13.99 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
453.54 | 58.59B | 2.46B | -319.09M | -52.09M | -2.47 |
|
REGN
Regeneron Pharmaceuticals Inc
|
567.22 | 61.25B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ARGX
Argen X Se Adr
|
733.66 | 43.23B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
318.73 | 36.53B | 3.81B | -644.79M | -669.77M | -6.24 |
Vyne Therapeutics Inc Stock (VYNE) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-07-31 | Herabstufung | BTIG Research | Buy → Neutral |
| 2024-11-18 | Eingeleitet | BTIG Research | Buy |
| 2021-12-06 | Fortgesetzt | H.C. Wainwright | Buy |
Vyne Therapeutics Inc Aktie (VYNE) Neueste Nachrichten
Using data models to predict VYNE Therapeutics Inc. stock movementProfit Target & Free High Return Stock Watch Alerts - Newser
Can VYNE Therapeutics Inc. deliver alphaPortfolio Update Report & AI Optimized Trading Strategy Guides - khodrobank.com
What MACD and RSI say about VYNE Therapeutics Inc.July 2025 Reactions & Consistent Profit Trade Alerts - Newser
Published on: 2025-09-03 11:26:00 - khodrobank.com
Is it time to cut losses on VYNE Therapeutics Inc.Market Sentiment Review & Risk Adjusted Buy/Sell Alerts - Newser
VYNE Therapeutics Inc. stock prediction for this week2025 Analyst Calls & Weekly High Momentum Picks - Newser
Why VYNE Therapeutics Inc. is moving todayRate Hike & Daily Growth Stock Investment Tips - Newser
Is VYNE Therapeutics Inc. stock poised for growth2025 Short Interest & Reliable Momentum Entry Alerts - Newser
What to do if you’re stuck in VYNE Therapeutics Inc.Quarterly Profit Report & Fast Gain Swing Trade Alerts - Newser
Using economic indicators to assess VYNE Therapeutics Inc. potentialJuly 2025 Sector Moves & Stock Portfolio Risk Management - Newser
How institutional ownership impacts VYNE Therapeutics Inc. stockQuarterly Trade Review & High Conviction Buy Zone Alerts - Newser
VYNE Therapeutics Inc. stock momentum explainedWeekly Stock Summary & Community Driven Trade Alerts - Newser
Institutional scanner results for VYNE Therapeutics Inc.Market Performance Recap & Fast Gaining Stock Strategy Reports - Newser
Is VYNE Therapeutics Inc. a candidate for recovery playProduct Launch & Fast Exit/Entry Strategy Plans - Newser
How to interpret RSI for VYNE Therapeutics Inc. stockJuly 2025 Market Mood & Real-Time Buy Signal Notifications - Newser
Using data filters to optimize entry into VYNE Therapeutics Inc.Long Setup & Fast Gain Swing Trade Alerts - Newser
Will VYNE Therapeutics Inc. benefit from rate cutsTrade Entry Summary & Proven Capital Preservation Tips - khodrobank.com
Day Trade: What is VYNE Therapeutics Inc.’s valuation compared to sectorMarket Risk Report & Intraday High Probability Alerts - khodrobank.com
How cyclical is VYNE Therapeutics Inc.’s revenue streamDollar Strength & Real-Time Stock Price Movement Reports - khodrobank.com
VYNE Therapeutics Inc. stock volume spike explainedQuarterly Investment Review & Weekly Hot Stock Watchlists - Newser
How is VYNE Therapeutics Inc. managing supply chain issuesQuarterly Trade Report & Long-Term Capital Growth Strategies - khodrobank.com
Multi asset correlation models including VYNE Therapeutics Inc.Weekly Trend Summary & Community Shared Stock Ideas - Newser
VYNE Therapeutics Inc. Rebounds From Oversold Zone — Now What getLinesFromResByArray error: size == 0 - thegnnews.com
Will VYNE Therapeutics Inc. stock recover after recent dropQuarterly Portfolio Report & Precise Entry and Exit Recommendations - Newser
Is VYNE Therapeutics Inc. stock entering bullish territoryPortfolio Gains Report & Verified Short-Term Plans - Newser
Sector ETF performance correlation with VYNE Therapeutics Inc.July 2025 Gainers & Stepwise Trade Signal Implementation - Newser
Will VYNE Therapeutics Inc. price bounce be sustainableBond Market & Safe Capital Growth Tips - Newser
Is this a good reentry point in VYNE Therapeutics Inc.Quarterly Growth Report & Stock Timing and Entry Methods - Newser
Finanzdaten der Vyne Therapeutics Inc-Aktie (VYNE)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.75%
1.11%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):